Apixaban trials for Atrial Fibrillation (AF)

All Apixaban trials · All Atrial Fibrillation (AF) trials

Phase breakdown

Recruiting trials studying Apixaban for Atrial Fibrillation (AF)

• Net Clinical Benefit of Edoxaban Versus Apixaban in Patients With Atrial Fibrillation and Coronary Artery Disease
  NCT07753200 · Phase: Phase 4 · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
  NCT07175428 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 81 locations
• Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
  NCT07626411 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 32 locations

Common questions

How many trials study Apixaban for Atrial Fibrillation (AF)?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.